Haldol im and qt prolongation

This information should not be used to decide whether or not to take Haldol or any other medicine. Only the healthcare provider has the knowledge and training to decide which medicines are right for a specific patient. This information does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this medicine. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to Haldol. This information is not specific medical advice and does not replace information you receive from the healthcare provider. You must talk with the healthcare provider for complete information about the risks and benefits of using this medicine.

Importance of women informing clinicians if they are or plan to become pregnant or plan to breast-feed. 187 190 Importance of clinicians informing patients about the benefits and risks of taking antipsychotics during pregnancy (see Fetal/Neonatal Morbidity and Mortality under Cautions). 187 190 Importance of advising patients not to stop taking haloperidol if they become pregnant without consulting their clinician; abruptly discontinuing antipsychotic agents may cause complications. 190 Importance of advising patients not to breast-feed during haloperidol therapy. 187

Haldol im and qt prolongation

haldol im and qt prolongation

Media:

haldol im and qt prolongationhaldol im and qt prolongationhaldol im and qt prolongationhaldol im and qt prolongation